IGF-1 administration has been shown to reduce the serum glucose levels not only in healthy individuals, but also in those with insulin resistance, type I diabetes, and T2DM [18], and it is regarded as a promising drug for the treatment of diabetes [18]. Here, IGF1 is linked to type 2 diabetes mellitus.